Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Tirosint (levothyroxine sodium capsules)
Company: Institut Biochimique SA (IBSA)
NDA: 22121
Approval Date: 08/01/2007


Date created: Sepember 5, 2008

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.